Table 11.
Drug | Dosage (mg) | Level of evidence | Scientific strength of evidence | Clinical effectiveness | Adverse events | Level of recommendation | Comments |
---|---|---|---|---|---|---|---|
Antidepressants | |||||||
Amitriptyline | 25–75 | A | +++ | +++ | Frequent, not severe | I | Useful in patients with comorbid anxiety, depression, insomnia. Contraindicated in the case of glaucoma and prostatic hypertrophy |
Clomipramine | 10–150 | B | ++ | ++ | Frequent, not severe | II | |
Fluvoxamine | 50–100 | B | ++ | ++ | Frequent, not severe | II | |
Maprotilin | 75 | B | +++ | ++ | Frequent, not severe | II | |
Mianserin | 30–60 | A | ++ | + | Frequent, not severe | II | |
Mirtazapine | 15–30 | A | +++ | +++ | Frequent, not severe | I | Particularly indicated in patients with anxiety, depression, insomnia. It may induce somnolence |
Venlafaxine | 75–150 | B | ++ | ++ | Frequent, not severe | II | |
Muscle relaxants | |||||||
Tizanidine oral | 3–12 | B | +++ | +++ | Frequent, not severe | II | Especially useful in the case of pericranial muscle tenderness |
Benzodiazepines | |||||||
Diazepam | 5 | B | ++ | ++ | Occasional, not severe | II | |
Other drugs | |||||||
Topiramate oral | 25–100 | C | +++ | +++ | Frequent, not severe. Rarely severe | II |